Rhodiola Rosea — The Stress Adaptogen
Rhodiola rosea is a Scandinavian adaptogen used for centuries to combat fatigue and stress. It is the most clinically studied adaptogen for mental and physical fatigue, with a strong safety profile and multiple RCTs demonstrating effects on cortisol, cognitive performance, and exercise capacity.
Mechanism of Action
Salidroside and rosavin (the active compounds) inhibit monoamine oxidase (MAO), increasing serotonin, dopamine, and norepinephrine. They also activate AMPK, reduce cortisol via HPA axis modulation, and protect mitochondria from oxidative stress. Rhodiola has been shown to extend lifespan in C. elegans and Drosophila.
Human Trial Evidence
A 2012 BMC Complementary Medicine systematic review of 11 RCTs found Rhodiola significantly reduced mental fatigue, improved cognitive performance, and reduced cortisol response to stress. A 2015 Phytomedicine RCT showed 400 mg/day Rhodiola extract reduced burnout symptoms and improved attention over 12 weeks.
Dosing Protocol
300–600 mg/day standardized to 3% rosavins + 1% salidroside. Best taken in the morning (stimulating effect). Cycle 4–6 weeks on, 1–2 weeks off. Take on an empty stomach for best absorption.
Safety & Contraindications
Well-tolerated. Mild stimulating effect — avoid in the evening. May cause mild dizziness or dry mouth at initiation. Avoid in bipolar disorder (may trigger mania). Mild MAO inhibition — caution with SSRIs/SNRIs (serotonin syndrome risk at high doses).